Table 4.
Univariate and multivariable Cox regression analysis of disease-free survival*
| Univariate analysis
|
Multivariable analysis†
|
|||
|---|---|---|---|---|
| Hazard ratio (95% CI) | p | Hazard ratio (95% CI) | p | |
| Age | 1·0 (0·9–1·0) | 0·63 | ·· | ·· |
|
| ||||
| Sex | ||||
| Men | 1·0 (reference) | 0·31 | ·· | ·· |
| Women | 1·3 (0·7–2·5) | ·· | ||
|
| ||||
| Histological type | ||||
| Intestinal | 1·0 (reference) | 0·67 | ·· | ·· |
| Diffuse | 1·1 (0·6–2·1) | ·· | ||
|
| ||||
| T | ||||
| T1–T2 | 1·0 (reference) | 0·001 | ·· | ·· |
| T3–T4 | 3·1 (1·5–6·1) | ·· | ||
|
| ||||
| N | ||||
| Negative | 1·0 (reference) | <0·0001 | ·· | ·· |
| Positive | 5·5 (2·1–14·2) | ·· | ||
|
| ||||
| Stage | ||||
| I–II | 1·0 (reference) | <0·0001 | 1·0 (reference) | <0·0001 |
| III–IV | 4·5 (2·2–9·2) | 5·2 (2·4–11·2) | ||
|
| ||||
| let-7b expression | ||||
| High | 1·0 (reference) | 0·003 | 1·0 (reference) | 0·001 |
| Low | 2·7 (1·4–5·4) | 3·2 (1·6–6·6) | ||
|
| ||||
| let-7g expression | ||||
| High | 1·0 (reference) | 0·002 | 1·0 (reference) | 0·042 |
| Low | 2·7 (1·4–5·2) | 2·0 (1·0–3·9) | ||
|
| ||||
| miR-19a expression | ||||
| High | 1·0 (reference) | 0·032 | 1·0 (reference) | <0·0001 |
| Low | 2·0 (1·0–3·6) | 3·3 (1·7–6·5) | ||
|
| ||||
| miR-495 expression | ||||
| Low | 1·0 (reference) | 0·035 | 1·0 (reference) | 0·007 |
| High | 1·9 (1·0–3·6) | 2·4 (1·2–4·7) | ||
|
| ||||
| miR-410 expression | ||||
| Low | 1·0 (reference) | 0·016 | ·· | ·· |
| High | 2·2 (1·1–4·3) | ·· | ||
|
| ||||
| miR-433 expression | ||||
| High | 1·0 (reference) | 0·011 | ·· | ·· |
| Low | 2·1 (1·1–4·0) | ·· | ||
No patients were censored before first event (disease recurrence).
For the final model of multivariable analysis, stage, let-7b, let-7g, miR-19a, and miR-495 were included.